Dure geneesmiddelen * (extramuraal), de vergoeding in 2019

  • Raming voor de totale Zvw-populatie
  2015 2016 2017 2018 2019
Rang
2019
ATC-code  
1 R07AX30 Ivacaftor met lumacaftor (Orkambi ®) . . 5.765.200 89.977.700 67.618.300
2 J06BA02 Immunoglobuline normaal intravasculair (Nanogam ®) 41.989.900 48.124.700 53.707.300 61.820.000 67.284.900
3 N04BA02 Levodopa met decarboxylaseremmer (Sinemet ®) 28.568.100 31.931.800 35.995.500 38.667.400 43.312.700
4 C10AX13 Evolocumab (Repatha ®) . 5.752.200 20.209.900 33.380.700 39.972.700
5 L04AX07 Dimethylfumaraat (Tecfidera ®) 16.075.200 20.508.000 23.228.100 32.246.400 38.396.100
6 L04AD02 Tacrolimus (Prograft ®) 26.778.400 28.406.600 29.575.200 31.590.300 33.159.100
7 J05AR13 Lamivudine met abacavir en dolutegravir (Triumeq ®) 16.215.800 28.113.000 32.077.600 35.228.800 32.832.500
8 J05AR18 Emtricitabine tenofovir alafenamide elvitegravir cobicista (Genvoya ®) . 8.899.200 26.089.100 33.745.400 31.901.400
9 C10AX14 Alirocumab (Praluent ®) . 1.933.100 9.789.700 20.152.500 30.215.700
10 B03XA02 Darbepoetine alfa (Aranesp ®) 24.510.900 24.146.400 24.134.500 25.993.000 28.491.300
11 L04AA27 Fingolimod (Gilenya ®) 21.522.300 22.922.700 24.383.400 27.139.200 27.436.800
12 H01CB03 Lanreotide (Somatuline ®) 15.102.000 16.764.400 18.777.100 20.823.000 23.329.200
13 H01CB02 Octreotide (Sandostatine ®) 24.552.000 24.451.100 23.381.300 23.425.700 22.691.300
14 R07AX02 Ivacaftor (Kalydeco ®) 4.888.100 9.158.500 9.043.200 10.484.000 22.191.700
15 A09AA02 Multi-enzymen (lipase protease enz) (Creon ®) 15.975.500 16.826.000 17.931.600 18.893.500 21.080.200
16 C02KX04 Macitentan (Opsumit ®) 7.469.900 12.536.400 15.309.000 18.914.600 20.294.500
17 J05AR20 Emtricitabine met tenofoviralafenamide en bictegravir (Biktarvy ®) . . . 865.390 15.874.400
18 J05AX12 Dolutegravir (Tivicay ®) 6.356.400 10.339.000 12.187.500 14.405.900 15.837.200
19 L02AE02 Leuproreline (Lucrin pds ®) 14.299.900 14.602.400 15.245.300 15.711.000 15.811.800
20 L03AA13 Pegfilgrastim (Neulasta ®) 23.793.500 17.683.500 14.646.000 15.901.900 15.459.700
  Totaal 288.097.900 343.099.000 411.476.500 569.366.390 613.191.500